Comments
Loading...

Immunic

IMUXNASDAQ
Logo brought to you by Benzinga Data
$1.05
-0.02-1.87%
At close: -
$1.05
-0.00030-0.03%
After Hours: 4:24 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$35.00
Lowest Price Target1
$5.00
Consensus Price Target1
$14.90

Immunic (NASDAQ:IMUX) Stock, Analyst Ratings, Price Targets, Forecasts

Immunic Inc has a consensus price target of $14.9 based on the ratings of 10 analysts. The high is $35 issued by Aegis Capital on August 8, 2022. The low is $5 issued by Leerink Partners on September 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., EF Hutton, and EF Hutton on November 25, 2024, November 7, 2024, and October 22, 2024, respectively. With an average price target of $14.67 between HC Wainwright & Co., EF Hutton, and EF Hutton, there's an implied 1297.22% upside for Immunic Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
1
Aug
3
Sep
1
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
EF Hutton
Leerink Partners
B. Riley Securities
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Immunic

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Immunic (IMUX) stock?

A

The latest price target for Immunic (NASDAQ:IMUX) was reported by HC Wainwright & Co. on November 25, 2024. The analyst firm set a price target for $10.00 expecting IMUX to rise to within 12 months (a possible 852.65% upside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Immunic (IMUX)?

A

The latest analyst rating for Immunic (NASDAQ:IMUX) was provided by HC Wainwright & Co., and Immunic initiated their buy rating.

Q

When was the last upgrade for Immunic (IMUX)?

A

There is no last upgrade for Immunic

Q

When was the last downgrade for Immunic (IMUX)?

A

The last downgrade for Immunic Inc happened on October 21, 2022 when SVB Leerink changed their price target from $9 to $5 for Immunic Inc.

Q

When is the next analyst rating going to be posted or updated for Immunic (IMUX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immunic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immunic was filed on November 25, 2024 so you should expect the next rating to be made available sometime around November 25, 2025.

Q

Is the Analyst Rating Immunic (IMUX) correct?

A

While ratings are subjective and will change, the latest Immunic (IMUX) rating was a initiated with a price target of $0.00 to $10.00. The current price Immunic (IMUX) is trading at is $1.05, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch